YM90K is a potent and selective AMPA receptor antagonist with neuroprotective effects; it shows significant protective activity against AMPA- or kainate-induced neurotoxicity in rat striatum; exhibits potent suppressive activity against audiogenic seizures in DBA/2 mice (ED50 = 2.54 mg/kg, i.p.); prevents delayed neuronal death in the hippocampal CA1 region in Mongolian gerbils following global ischemia when administered 1 h after 5-min ischemia; demonstrates a therapeutic time window of up to 6 h for its neuroprotective effect; and reduces ischemic damage volume in the cerebral cortex in F344 rats in a focal ischemia model.